2 Clarke Drive
Cranbury, NJ 08512
© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
April 19th 2022
Eirwen M. Miller, MD, discusses the current treatment landscape of ovarian cancer.
July 14th 2021
Eirwen M. Miller, MD, discusses the safety and efficacy of veliparib vs other PARP inhibitors used in the treatment of patients with ovarian cancer.
April 27th 2021
Eirwen M. Miller, MD, discusses the potential utility of sequential PARP inhibition in ovarian cancer.